Company Filing History:
1 out of 1 
1 out of 1 
1 out of 23 
Years Active: 2023
Title: Patrick Reichenbach: Innovator in Kinase Mutants
Introduction
Patrick Reichenbach is a notable inventor based in La Sarraz, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the design of kinase mutants. His work focuses on enhancing the sensitivity of target kinases to specific inhibitors, which has important implications for cancer treatment.
Latest Patents
Patrick Reichenbach holds a patent titled "Kinase mutants and uses thereof." This invention relates to methods for designing kinase mutants that can be reprogrammed to respond to specific inhibitors. These inhibitors have little or no affinity for the wild-type target kinase. The patent also covers vectors or cells expressing these mutated kinases, along with their compositions and uses for the prevention and treatment of diseases, particularly cancer.
Career Highlights
Throughout his career, Patrick has worked with esteemed organizations such as the Swiss Institute of Bioinformatics and the Centre Hospitalier Universitaire Vaudois. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Patrick's notable coworkers include Olivier Michielin and Vincent Zoete. Their collaborative efforts have further advanced the research and development of kinase mutants.
Conclusion
Patrick Reichenbach's innovative work in the field of kinase mutants showcases his dedication to advancing cancer treatment methodologies. His contributions through patents and collaborations highlight the importance of research in biotechnology.